How Easily Can K-One Technology Berhad Raise Cash?
While K-One Technology Berhad seems to be in a fairly good position, it's still worth considering how easily it could raise more cash, even just to fuel faster growth. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.
K-One Technology Berhad's cash burn of RM11m is about 11% of its RM96m market capitalisation. As a result, we'd venture that the company could raise more cash for growth without much trouble, albeit at the cost of some dilution.
A new low for no peculiar reason is understated. No changes in management team, no losses in the past quarter. Revenue increase, ready cash for any potential acquisition. Covid cases going up, but no lockdown. USD at ATH, these are all positive reasons for the share to spike up in the 2H of the year TP rm0.49 Mid Term, rm0.75 Long Term
Q6. At what stage (may be in term of percentage) the development on the ventilator has achieved? How much MIDA Grant has been utilised as at to date? A6. The development of the ventilator is progressing well. As it is a Class C medical device, i.e. a semi-invasive medical device, it needs to go through numerous clinical trials/tests to ensure that it is safe for use. Therefore, the management would need to work on this with care and have collaborated with 2 prestigious universities in Malaysia to conduct the tests on the ventilator which would be branded as “Medkaire”. Once the clinical trials are completed in the next few months, the application to MDA for its final approval would be submitted. Applications in conjunction with clinical trials are planned for submission for FDA and CE approvals which are necessary for the export markets. The development of the ventilator has taken a long time as it must ensure that the device is safe for use as safety is of utmost importance. The ventilator business is for long term and does not depend on COVID- 19 only as the device can be used for other respiratory diseases or in aiding breathing difficulty. The Company is thankful for the MIDA Grant. It is progressing well and the management had submitted claims for work done based on milestones achieved.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....